Calyxt

Following a number of real estate investment trusts, tech companies and pharmaceuticals, six companies are set to join the public markets this week. Calyxt, Inc. (CLXT) will issue more than 6 million shares between $15 and $18 Thursday on the Nasdaq. Through its gene-editing technology, the...